These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

283 related items for PubMed ID: 10590913

  • 21. Leukotriene modifiers for asthma treatment.
    Montuschi P, Peters-Golden ML.
    Clin Exp Allergy; 2010 Dec; 40(12):1732-41. PubMed ID: 21059119
    [Abstract] [Full Text] [Related]

  • 22. Antileukotriene drugs in the treatment of asthma.
    Mastalerz L, Kumik J.
    Pol Arch Med Wewn; 2010 Mar; 120(3):103-8. PubMed ID: 20332717
    [Abstract] [Full Text] [Related]

  • 23. Review of recent results of montelukast use as a monotherapy in children with mild asthma.
    Wahn U, Dass SB.
    Clin Ther; 2008 Mar; 30 Spec No():1026-35. PubMed ID: 18640477
    [Abstract] [Full Text] [Related]

  • 24. A risk-benefit assessment of antileukotrienes in asthma.
    Smith LJ.
    Drug Saf; 1998 Sep; 19(3):205-18. PubMed ID: 9747667
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Antileukotrienes in upper airway inflammatory diseases.
    Cingi C, Muluk NB, Ipci K, Şahin E.
    Curr Allergy Asthma Rep; 2015 Nov; 15(11):64. PubMed ID: 26385352
    [Abstract] [Full Text] [Related]

  • 28. Leukotrienes in asthma. The potential therapeutic role of antileukotriene agents.
    Smith LJ.
    Arch Intern Med; 1996 Oct 28; 156(19):2181-9. PubMed ID: 8885816
    [Abstract] [Full Text] [Related]

  • 29. The prospects for long-term intervention in asthma with antileukotrienes.
    Smith LJ.
    Clin Exp Allergy; 1998 Nov 28; 28 Suppl 5():154-63; discussion 171-3. PubMed ID: 9988462
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Anti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma in adults and children.
    Ng D, Salvio F, Hicks G.
    Cochrane Database Syst Rev; 2004 Nov 28; (2):CD002314. PubMed ID: 15106175
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Comparative efficacy of inhaled corticosteroids and antileukotriene drugs in asthma.
    Smith LJ.
    BioDrugs; 2001 Nov 28; 15(4):239-49. PubMed ID: 11437689
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Asthma controller therapy: role of antileukotrienes, a new therapeutic class.
    Allegra L, Canonica GW, Donner CF, Fogliani V, Melillo G, Mistretta A, Paggiaro PL, Rossi GA, Sanguinetti CM, Vignola M.
    Monaldi Arch Chest Dis; 1999 Apr 28; 54(2):136-45. PubMed ID: 10394828
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Leukotrienes, leukotriene receptor antagonists and leukotriene synthesis inhibitors in asthma: an update. Part II: clinical studies with leukotriene receptor antagonists and leukotriene synthesis inhibitors in asthma.
    Devillier P, Baccard N, Advenier C.
    Pharmacol Res; 1999 Jul 28; 40(1):15-29. PubMed ID: 10378986
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.